Pediatric Lamisil granules get FDA nod

October 3, 2007

Lamisil oral granules are approved by the FDA for tinea capitis

Terbinafine (Lamisil, Novartis) oral granules have been approved for the treatment of tinea capitis in children aged four years and older. Novartis developed the new formulation in response to a written request from the FDA for the product. The granules can be sprinkled on food and are approved to be administered once daily for six weeks.

Click here to see more articles from Drug Topics Daily News.

To go to the Drug Topics homepage, click here.